A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma Meeting Abstract


Authors: Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; Grisham, R. N.; Kyi, C.; Soldan, K.; Lichtman, S. M.; Ligresti, L.; Schweber, S. J.; Singh, J. C.; Troso-Sandoval, T. A.; Aghajanian, C.; Makker, V.
Abstract Title: A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 334s
Language: English
ACCESSION: WOS:000487345805573
DOI: 10.1200/JCO.2019.37.15_suppl.5582
PROVIDER: wos
Notes: Meeting Abstract: 5582 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Vicky Makker
    108 Makker
  2. Jason Konner
    105 Konner
  3. Dmitriy Zamarin
    84 Zamarin
  4. Qin Zhou
    140 Zhou
  5. Stuart Lichtman
    191 Lichtman
  6. Alexia Elia Iasonos
    209 Iasonos
  7. Rachel Nicole Grisham
    54 Grisham
  8. William P Tew
    154 Tew
  9. Karen Anne Cadoo
    65 Cadoo
  10. Jasmeet Chadha Singh
    16 Singh
  11. Krysten Nicole Soldan
    3 Soldan
  12. Imogen Caird
    2 Caird
  13. Chrisann Kyi Kyi
    1 Kyi
Related MSK Work